Thermo Fisher Scientific - AI Stock Analysis

Analysis generated January 9, 2026

Thermo Fisher Scientific Inc. (NYSE: TMO) is a leading global provider of scientific instrumentation, reagents and consumables, and software services. The company operates in various segments such as Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The company serves pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies. Its mission is to enable their customers to make the world healthier, cleaner, and safer.

Fundamental Analysis

Revenue: Thermo Fisher Scientific reported revenue of $11.1 billion for the last quarter. This represents a 2.46% increase compared to the previous quarter and a 4.94% increase year over year. The positive growth in revenue is a promising sign for the company, indicating robust demand for its products and services.

Net Income: The net income for the last quarter stood at $1.62 billion, which is a slight decrease of 0.06% quarter over quarter and a 0.86% decrease year over year. This decline in net income might raise some concerns among investors about the company’s profitability.

EBITDA: The EBITDA for the last quarter was $2.84 billion, up by 1.43% from the previous quarter but down by 2.34% year over year. While the quarter over quarter growth is positive, the year over year decline could be a cause for concern.

P/E Ratio: The current P/E ratio is 35.84, which may be considered high. A high P/E ratio could indicate potential overvaluation and a bearish outlook.

Insider Sales: Recent insider selling might be a bearish signal, suggesting that even those closest to the company may not be optimistic about its near-term prospects.

Technical Analysis

Stock Price: The current stock price is $612.00, marking an 8.77% increase over the past month and a 13.25% increase over the last year. This suggests a strong bullish trend in both the short and long term.

SMA10: The current 10-day simple moving average (SMA10) is 600.40, higher than the previous SMA10 of 597.55, indicating an upward trend in price movement.

RSI: The Relative Strength Index (RSI) is currently at 84.1, which could signal an overbought condition and hint at a possible bearish correction in the near future.

Alternative Data Analysis

Job Postings: There are currently 2,956 open positions at Thermo Fisher Scientific, a 28% increase in the last couple of months. This suggests that the company is expanding and is in a growth phase, which is a healthy sign.

Employee Sentiment: The business outlook among employees at Thermo Fisher Scientific remains neutral, indicating neither extreme optimism nor pessimism.

Website Traffic: The company's website has an estimated 4.8 million visitors, but this number is down by 18% over the last couple of months. A decline in web traffic could indicate a loss of customer interest or potential competitive pressures.

Social Media Engagement: Thermo Fisher Scientific has 86,000 Instagram followers, up by 5% recently, showing increased interest. However, Twitter followers are down by 1% to 65,000, which may indicate a slight decline in engagement on that platform.

AltIndex AI Score: The AI score is 41, indicating a hold signal based on combined fundamental, technical, and alternative data analysis.

Conclusion and Recommendation

Thermo Fisher Scientific presents a mixed but slightly skewed positive outlook. On the fundamental side, strong revenue growth is a significant plus, but declining net income and EBITDA year over year are concerns. The high P/E ratio and insider sales also raise caution flags about overvaluation.

Technically, the stock price has shown impressive short and long-term gains, indicating a bullish trend. However, the high RSI suggests a potential overbought condition.

Alternative data mostly points to growth and expansion, but declining web traffic and stagnant employee sentiment warrant close monitoring.

Bearing all factors in mind, a cautious hold recommendation is suggested. Investors may want to wait for a clearer indication of sustained growth and profitability before making significant changes to their positions.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.